Shares in Verve Therapeutics (NASDAQ: VERV) soared 80.5% this week on the news of an agreement for Eli Lilly (NYSE: LLY) to ...

Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.

Eli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.

A dramatic pullback in public biotech investment catalyzed by economic and regulatory upheaval is putting even more stress on ...

GigaCloud Technology Inc. (GCT) concluded the recent trading session at $18.24, signifying a +1.33% move from its prior day's close.